Published in Blood on July 01, 1987
Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr (2010) 1.65
Modifiers of von Willebrand factor identified by natural variation in inbred strains of mice. Blood (2009) 1.58
Neonatal coagulation problems. Arch Dis Child Fetal Neonatal Ed (2004) 1.53
Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J (1990) 1.45
Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Arch Dis Child Fetal Neonatal Ed (2003) 1.45
Activation of the L-arginine nitric oxide pathway in severe sepsis. Arch Dis Child (1997) 1.37
Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions. Pharm Res (2010) 1.26
The neonatal coagulation system and the vitamin K deficiency bleeding - a mini review. Wien Med Wochenschr (2008) 0.99
Neonatal thrombosis. J Clin Pathol (2000) 0.97
Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed (2004) 0.97
Autologous umbilical cord blood transfusion. Arch Dis Child Fetal Neonatal Ed (1995) 0.95
Anticoagulation in the young. Heart (2004) 0.94
The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol (2014) 0.93
Current and future management of pediatric venous thromboembolism. Am J Hematol (2012) 0.91
Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery. J Extra Corpor Technol (2010) 0.87
Thromboelastography of patients after fontan compared with healthy children. Pediatr Cardiol (2009) 0.87
Anticoagulation and thrombolysis in children. Tex Heart Inst J (1992) 0.86
Factor V Leiden and genetic defects of thrombophilia in childhood porencephaly. Arch Dis Child Fetal Neonatal Ed (1998) 0.85
Developmental changes in circulating IL-8/CXCL8 isoforms in neonates. Cytokine (2009) 0.85
Pediatric stroke. Childs Nerv Syst (2011) 0.84
Ornithine transcarbamylase deficiency: a possible risk factor for thrombosis. Pediatr Blood Cancer (2009) 0.83
Potential role of miRNAs in developmental haemostasis. PLoS One (2011) 0.83
In situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained anticoagulant release. J Biomed Mater Res A (2012) 0.82
Interaction of incontinentia pigmenti and factor VIII mutations in a female with biased X inactivation, resulting in haemophilia. J Med Genet (1993) 0.82
Warfarin pharmacogenomics in children. Pediatr Blood Cancer (2013) 0.82
Effects of in vitro adult platelet transfusions on neonatal hemostasis. J Thromb Haemost (2011) 0.82
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest (1992) 0.81
Perinatal asphyxia may present with features of neonatal atypical hemolytic uremic syndrome. Pediatr Nephrol (2007) 0.81
Protein S modulates the anticoagulant action of recombinant human activated protein C: a comparison between neonates and adults. Br J Pharmacol (2005) 0.80
Effects of gestational age and prenatal and perinatal events on the coagulation status in premature infants. Arch Dis Child Fetal Neonatal Ed (2003) 0.80
International normalized ratio testing with point-of-care coagulometer in healthy term neonates. BMC Pediatr (2014) 0.79
Assessment of neonatal platelet adhesion, activation, and aggregation. J Thromb Haemost (2016) 0.79
Coagulopathy after severe pediatric trauma. Shock (2014) 0.78
Neonatal plasminogen displays altered cell surface binding and activation kinetics. Correlation with increased glycosylation of the protein. J Clin Invest (1990) 0.78
Control of post-translational modifications in antithrombin during murine post-natal development by miR-200a. J Biomed Sci (2013) 0.78
Hemostatic response in paediatric patients undergoing cardiopulmonary bypass surgery. Pediatr Cardiol (2011) 0.78
Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency. Biologics (2010) 0.76
Renal vascular thrombosis in the newborn. Pediatr Nephrol (2015) 0.76
Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children. Wien Med Wochenschr (2011) 0.76
Neonatal haemostasis. Arch Dis Child (1989) 0.76
Comparison of routine laboratory measures of heparin anticoagulation for neonates on extracorporeal membrane oxygenation. J Extra Corpor Technol (2014) 0.75
Thrombelastography and sepsis. Crit Care (2007) 0.75
A practical approach to hemophilia care in children. Paediatr Child Health (2007) 0.75
Observational study of haemostatic dysfunction and bleeding in neonates with hypoxic-ischaemic encephalopathy. BMJ Open (2017) 0.75
Evaluation of transduction properties of an adenovirus vector in neonatal mice. Biomed Res Int (2015) 0.75
Massive Transfusion of 5 U Packed Redblood Cells, 3 U Fresh Frozen Plasma, and 160 cc of Platelets in a 14-Month-Old Patient. Am J Case Rep (2016) 0.75
The characteristics of thrombin in osteoarthritic pathogenesis and treatment. Biomed Res Int (2014) 0.75
Determination of Age-Dependent Reference Ranges for Coagulation Tests Performed Using Destiny Plus. Iran J Pediatr (2016) 0.75
Fibrin Network Changes in Neonates after Cardiopulmonary Bypass. Anesthesiology (2016) 0.75
A Case of Hemophilia A Presenting in a Neonate and a Review of the Literature. Glob Pediatr Health (2017) 0.75
Neonatal Venous Thromboembolism. Front Pediatr (2017) 0.75
Extracorporeal Life Support for Pediatric Heart Failure. Front Pediatr (2016) 0.75
Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass. Anesthesiology (2015) 0.75
Coagulopathy and transfusion therapy in pediatric liver transplantation. World J Gastroenterol (2016) 0.75
Intrauterine extremity gangrene and cerebral infarction at term: a case report. Case Rep Pediatr (2011) 0.75
Clinical profile of hemophilia patients in Jodhpur Region. Asian J Transfus Sci (2016) 0.75
Pregnancy outcome after maternal intoxication with phenprocoumon. Br J Clin Pharmacol (2011) 0.75
Treatment and follow-up of venous thrombosis in the neonatal intensive care unit: a retrospective study. J Perinatol (2016) 0.75
Multiple presence of prothrombotic risk factors in Croatian children with arterial ischemic stroke and transient ischemic attack. Croat Med J (2013) 0.75
Alterations in the Coagulation System during Major Visceral Surgery in Children. Surg Res Pract (2014) 0.75
Anticoagulation Management and Monitoring during Pediatric Extracorporeal Life Support: A Review of Current Issues. Front Pediatr (2016) 0.75
Effect of breastfeeding on serum osteoprotegerin and soluble receptor activator of nuclear factor-kappa B ligand in full term neonates. Iran Red Crescent Med J (2013) 0.75
[Regional anesthesia procedures in childhood: Austrian interdisciplinary recommendations on pediatric perioperative pain management]. Schmerz (2014) 0.75
[Prevention of perioperative venous thromboembolism in children]. Wien Med Wochenschr (2009) 0.75
Plasmin generation and fibrinolysis in pediatric patients undergoing cardiopulmonary bypass surgery. Pediatr Cardiol (2011) 0.75
Polyphosphate in Neonates: Less Shedding from Platelets and Divergent Prothrombotic Capacity Due to Lower TFPI Levels. Front Physiol (2017) 0.75
Anticoagulant action of melagatran: a comparison between neonates and adults using calibrated automated thrombography (CAT). Eur J Pediatr (2006) 0.75
Role of Plasma Fibrinogen in Diagnosis and Prediction of Short Term Outcome in Neonatal Sepsis. Indian J Hematol Blood Transfus (2016) 0.75
Continuous Antithrombin III Administration in Pediatric Veno-Arterial Extracorporeal Membrane Oxygenation. J Pediatr Pharmacol Ther (2017) 0.75
Effectiveness of prothrombin complex concentrate (PCC) in neonates and infants with bleeding or risk of bleeding: a systematic review and meta-analysis. Eur J Pediatr (2017) 0.75
A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature (2000) 47.15
Life with 6000 genes. Science (1996) 41.51
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1984) 20.61
Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care (2005) 12.73
A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol Rev (1987) 7.00
Internists' attitudes about clinical practice guidelines. Ann Intern Med (1994) 6.55
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Natl Acad Sci U S A (2001) 5.19
Inability of trained nurses to perform basic life support. Br Med J (Clin Res Ed) (1987) 5.08
Cerebral sinovenous thrombosis in children. N Engl J Med (2001) 4.81
Green fluorescent protein as a marker for gene expression and subcellular localization in budding yeast. Yeast (1996) 4.53
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med (1997) 4.47
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg (1997) 4.47
Surveying Saccharomyces genomes to identify functional elements by comparative DNA sequence analysis. Genome Res (2001) 4.22
Induction of labor as compared with serial antenatal monitoring in post-term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial Group. N Engl J Med (1992) 4.11
Function and regulation of yeast hexose transporters. Microbiol Mol Biol Rev (1999) 3.96
Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord (2000) 3.90
Three different regulatory mechanisms enable yeast hexose transporter (HXT) genes to be induced by different levels of glucose. Mol Cell Biol (1995) 3.74
Two glucose transporters in Saccharomyces cerevisiae are glucose sensors that generate a signal for induction of gene expression. Proc Natl Acad Sci U S A (1996) 3.54
Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science (1991) 3.41
The binding of thrombin to the surface of human platelets. J Biol Chem (1974) 3.41
Disability: a model and measurement technique. Br J Prev Soc Med (1976) 3.41
Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis. Clin Oncol (R Coll Radiol) (2002) 3.33
Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust (1993) 3.28
Application of operant conditioning procedures to the behavior problems of an autistic child: a follow-up and extension. Behav Res Ther (1967) 3.23
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet (1994) 3.12
Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression. Proc Natl Acad Sci U S A (1991) 3.00
Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle. EMBO J (1997) 2.97
Regulated nuclear translocation of the Mig1 glucose repressor. Mol Biol Cell (1997) 2.96
Glucose sensing and signaling by two glucose receptors in the yeast Saccharomyces cerevisiae. EMBO J (1998) 2.96
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med (1988) 2.85
Development of the Resident Assessment Instrument--Mental Health (RAI-MH). Hosp Q (2001) 2.84
Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery (1998) 2.71
Genetic evidence that zinc is an essential co-factor in the DNA binding domain of GAL4 protein. Nature (1987) 2.71
Two systems of glucose repression of the GAL1 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1990) 2.65
The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy (1994) 2.58
Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev (2007) 2.52
Canadian pediatricians: demographic characteristics, perceptions of training, and continuing medical education. Can Med Assoc J (1980) 2.49
Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med (2001) 2.35
GRR1 of Saccharomyces cerevisiae is required for glucose repression and encodes a protein with leucine-rich repeats. Mol Cell Biol (1991) 2.34
Changing clinicians' behavior: a randomized controlled trial of fees and education. J Dent Res (2008) 2.34
The work of a clinical psychologist in primary care. J R Coll Gen Pract (1978) 2.31
Establishing a therapeutic range for heparin therapy. Ann Intern Med (1993) 2.31
Characterization of three related glucose repressors and genes they regulate in Saccharomyces cerevisiae. Genetics (1998) 2.27
Supernumerary teeth. Dent Update (1989) 2.23
Baseline staging tests in primary breast cancer: a practice guideline. CMAJ (2001) 2.22
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost (2004) 2.21
Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics (1995) 2.14
Effect of delivery method on outcomes in the very low-birth weight breech infant: is the improved survival related to cesarean section or other perinatal care maneuvers? Am J Obstet Gynecol (1983) 2.14
tRNA genes as transcriptional repressor elements. Mol Cell Biol (1994) 2.10
Predictors of emotional outcomes of intensive care. Anaesthesia (2005) 2.10
The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women. J Psychosom Res (1989) 2.06
Galactose as a gratuitous inducer of GAL gene expression in yeasts growing on glucose. Gene (1989) 2.04
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. Eur Heart J (2003) 1.99
Two zinc-finger-containing repressors are responsible for glucose repression of SUC2 expression. Mol Cell Biol (1996) 1.92
Venous thromboembolic complications in children. J Pediatr (1993) 1.92
Maturation of the hemostatic system during childhood. Blood (1992) 1.89
The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of Saccharomyces cerevisiae. Curr Biol (1999) 1.89
Mutations that inactivate a yeast transcriptional regulatory protein cluster in an evolutionarily conserved DNA binding domain. Proc Natl Acad Sci U S A (1987) 1.86
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res (2000) 1.86
Rgt1p of Saccharomyces cerevisiae, a key regulator of glucose-induced genes, is both an activator and a repressor of transcription. Mol Cell Biol (1996) 1.85
MSP RFLP for X-linked proteolipid protein gene (PLP) identified with either rat or human PLP cDNA clone. Nucleic Acids Res (1987) 1.80
Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol (1990) 1.78
Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg (2000) 1.74
Educational package on hypertension for primary care physicians. Can Med Assoc J (1984) 1.73
The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr (2000) 1.72
A controlled trial of nurse practitioners in neonatal intensive care. Pediatrics (1996) 1.71
The association of alcohol and night driving with fatal snowmobile trauma: a case-control study. Ann Emerg Med (1994) 1.71
Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ (2001) 1.71
Does motor imagery training improve hand function in chronic stroke patients? A pilot study. Clin Rehabil (2004) 1.69
Chickenpox and stroke in childhood: a study of frequency and causation. Stroke (2001) 1.69
Decreased disability rate among 3-year-old survivors weighing 501 to 1000 grams at birth and born to residents of a geographically defined region from 1981 to 1984 compared with 1977 to 1980. J Pediatr (1989) 1.67
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1985) 1.67
A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med (1986) 1.67
Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev (2006) 1.67
Combined use of leg scanning and impedance plethysmography in suspected venous thrombosis. An alternative to venography. N Engl J Med (1977) 1.66
A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr (1993) 1.64
Analysis of URSG-mediated glucose repression of the GAL1 promoter of Saccharomyces cerevisiae. Genetics (1992) 1.64
Molecular cloning of the GAL80 gene from Saccharomyces cerevisiae and characterization of a gal80 deletion. Gene (1984) 1.64
The hematology of bacterial infections in premature infants. Pediatrics (1976) 1.61
Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. Mol Ther (2001) 1.61
Development of a self-administered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests. J Psychosom Res (1988) 1.60
Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest (1998) 1.59
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemost (2001) 1.58
Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr (1998) 1.58
Development of the human coagulation system in the healthy premature infant. Blood (1988) 1.57
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. J Biol Chem (1982) 1.57
Isolation and characterization of the ZWF1 gene of Saccharomyces cerevisiae, encoding glucose-6-phosphate dehydrogenase. Gene (1990) 1.57